Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. audio, 8-K earnings release, 10-Q stay in one workspace.
DSGN
$10.52
+3.04%
DSGN
· Design Therapeutics, Inc.
$10.52
+0.31 (+3.04%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2025 earnings call transcript
Market Cap
$653.81M
Shares
64.04M
Volume · Nov 9
70.68K
Avg daily vol (3M)
581.33K
All webcasts
Earnings call · FY2026 Q1
Design Therapeutics, Inc. (DSGN) Q1 2026 Earnings Call
Revenue
$0
Diluted EPS
-$0.29
Net income
-$17.64M
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Research materials
Open the source you need; every reader stays inside this workspace.
Listen to the call
Audio replay
Play the complete captured earnings call.
16:22
Audio
Audio replay
A speaker-labelled transcript is not available for this event yet.
SEC filing · Item 2.02
8-K earnings release
Filed Apr 28, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Apr 28, 2026 · complete as-filed document